About
Inhalable Drugs
Areas of Focus
Categories
Drug Delivery & Formulation
Team (11)
Charles Nelles
Charles Nelles
Aquilon Pharmaceuticals
team_member
Damien Thiéry
Damien Thiéry
Aquilon Pharmaceuticals
team_member
David Sylvestre
David Sylvestre
Aquilon Pharmaceuticals
team_member
Frank Pieters
Frank Pieters
Aquilon Pharmaceuticals
team_member
Gauthier van der Elst
Gauthier van der Elst
Aquilon Pharmaceuticals
team_member
Hassan Benameur
Hassan Benameur, PhD
Aquilon Pharmaceuticals
team_member
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
73
By Phase
PHASE1: 1PHASE2: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05148312Lead Sponsor
Single-dose AQ001S PK Study in Healthy Volunteers
PHASE1Completed
29 participants
Started: Nov 12, 2021 · Completed: Feb 21, 2022
NCT05000346Lead Sponsor
Clinical Trial to Assess the Efficacy and Safety of Inhaled AQ001S in the Management of Acute COVID-19 Symptoms
PHASE2Terminated
21 participants
Started: Nov 4, 2021 · Completed: Dec 21, 2022
NCT04933383Lead Sponsor
Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics
PHASE1/PHASE2Completed
23 participants
Started: Jul 23, 2021 · Completed: Jan 31, 2023
Locations (1)
Headquarters
Liege, Belgium
Map
Loading map...